Leukocyte alkaline phosphatase score in patients with cerebrovascular disease and in patients with primary and metastatic brain tumors
β Scribed by Natalio Walach; Amiram Guterman; Haim Rabinowitz; Suzana Kaufman; Beni Habot
- Publisher
- John Wiley and Sons
- Year
- 1991
- Tongue
- English
- Weight
- 217 KB
- Volume
- 46
- Category
- Article
- ISSN
- 0022-4790
No coin nor oath required. For personal study only.
β¦ Synopsis
Leukocyte alkaline phosphatase (LAP) activity in peripheral blood was determined in 54 patients with cerebrovascular disease (CVD), 11 patients with primary brain tumor, and 23 patients with metastatic brain tumor. The LAP score of the primary brain tumor patients (155 -+ 40) was significantly higher (lY0.03) than the LAP score for cerebrovascular disease patients (96 t 87). The LAP score levels of the metastatic brain tumor patients (251 ? 55) was significantly higher as compared with both the cerebrovascular disease ( K O . 0 0 1 ) and primary brain tumor groups (P<O.OOl). The LAP score could serve as an additional, although non-specific, marker to assist in the differentiation between cerebrovascular disease and brain tumors.
π SIMILAR VOLUMES
Leukocyte alkaline phosphatase (LAP) scores in peripheral blood and plasma carcinoembryonic antigen (CEA) levels were determined in 208 breast cancer patients with nonmetastatic disease. Patients were followed until clinical manifestations of metastases appeared. Then the LAP score and CEA level wer
## Abstract A 70βyearβold man with a history of peripheral vascular disease was treated initially with antidepressants, then bilateral electroconvulsive therapy (ECT) for a depressive illness. Apart from an episode of delirium following ECT he recovered fully. Four years later he relapsed. Lowβdose
## BACKGROUND. Cancer patients with single tumors live longer today due to earlier detection and improved treatment methods. For this reason, the authors see more patients who develop a second primary tumor. The etiology of the second tumor can be the same as the first, whether treatment-induced or
## Abstract Coronary artery disease is the cause of death in most patients who have transient ischemic attacks or stroke. Evaluation for this condition is not routinely performed in such patients, and no prospective studies have been reported. We prospectively examined 50 consecutive patients with